Clinical trial

AR-12286 Fixed Dose Combination to Lower Elevated Intraocular Pressure

NCT01474135

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2011-12-01

PhasePHASE2

Study timeline

Study start (unknown)2011-12-01Date precision: month

Registry last updated2016-09-23

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Glaucomaunresolved

Ocular Hypertensionunresolved

Interventions

0.25% AR-12286 / 0.004% travoprostDRUG

0.5% AR-12286, 0.004% travoprostDRUG

0.004% TravoprostDRUG

Sponsors & collaborators

Aerie Pharmaceuticalslead sponsor

Mapped research locations

St LouisMissouri, United States1 ClevelandOhio, United States1 RochesterNew York, United States1 Newport BeachCalifornia, United States1 El PasoTexas, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01474135 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.